Click here to get full coverage on Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility - tradingview.com

Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility  tradingview.com

Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility - tradingview.com

Click here to get full coverage on Briefs: Senores Pharmaceuticals and KIMS - Indian Pharma Post

Briefs: Senores Pharmaceuticals and KIMS  Indian Pharma Post

Briefs: Senores Pharmaceuticals and KIMS - Indian Pharma Post

Click here to get full coverage on Senores Pharma targets ₹3,000 crore revenue in 3-5 years, expands India and US capacity - CNBC TV18

Senores Pharma targets ₹3,000 crore revenue in 3-5 years, expands India and US capacity  CNBC TV18

Senores Pharma targets ₹3,000 crore revenue in 3-5 years, expands India and US capacity - CNBC TV18

Click here to get full coverage on Results: Senores Pharmaceuticals Limited Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st

Results: Senores Pharmaceuticals Limited Beat Earnings Expectations And Analysts Now Have New Forecasts  simplywall.st

Results: Senores Pharmaceuticals Limited Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st

Click here to get full coverage on Senores Pharma enters US government procurement market with Amerisyn JV - ET Manufacturing

Senores Pharma enters US government procurement market with Amerisyn JV  ET Manufacturing

Senores Pharma enters US government procurement market with Amerisyn JV - ET Manufacturing

Click here to get full coverage on Senores Pharmaceuticals Subsidiary Completes USFDA Inspection for Vadodara Facility - EquityBulls

Senores Pharmaceuticals Subsidiary Completes USFDA Inspection for Vadodara Facility  EquityBulls

Senores Pharmaceuticals Subsidiary Completes USFDA Inspection for Vadodara Facility - EquityBulls

Click here to get full coverage on Mercado Minerals Intersects 6.50 Metres of 256 g/t Silver and 1.46 g/t Gold from 43.60 m Depth at 5 Senores Vein Copalito Project - TMX Newsfile

Mercado Minerals Intersects 6.50 Metres of 256 g/t Silver and 1.46 g/t Gold from 43.60 m Depth at 5 Senores Vein Copalito Project  TMX Newsfile

Mercado Minerals Intersects 6.50 Metres of 256 g/t Silver and 1.46 g/t Gold from 43.60 m Depth at 5 Senores Vein Copalito Project - TMX Newsfile

Click here to get full coverage on Senores Pharma Posts 64% Q3 Revenue Growth On Strong Regulated Markets Push - bwhealthcareworld.com

Senores Pharma Posts 64% Q3 Revenue Growth On Strong Regulated Markets Push  bwhealthcareworld.com

Senores Pharma Posts 64% Q3 Revenue Growth On Strong Regulated Markets Push - bwhealthcareworld.com

Click here to get full coverage on Mitull M Dave Joins Senores Pharmaceuticals Limited as President – Strategic Group - hrtoday.in

Mitull M Dave Joins Senores Pharmaceuticals Limited as President – Strategic Group  hrtoday.in

Mitull M Dave Joins Senores Pharmaceuticals Limited as President – Strategic Group - hrtoday.in

Click here to get full coverage on Senores Pharmaceuticals Ltd Peer Comparison – Compare with Others - Value Research

Senores Pharmaceuticals Ltd Peer Comparison – Compare with Others  Value Research

Senores Pharmaceuticals Ltd Peer Comparison – Compare with Others - Value Research

Click here to get full coverage on Senores Pharmaceuticals Reports Strong Q1 FY27 Growth with Higher Profit - Machine Maker

Senores Pharmaceuticals Reports Strong Q1 FY27 Growth with Higher Profit  Machine Maker

Senores Pharmaceuticals Reports Strong Q1 FY27 Growth with Higher Profit - Machine Maker

Click here to get full coverage on Senores Pharma launches Deferiprone Tablets in US - Medical Dialogues

Senores Pharma launches Deferiprone Tablets in US  Medical Dialogues

Senores Pharma launches Deferiprone Tablets in US - Medical Dialogues

Click here to get full coverage on SENORES Forecast — Price Target — Prediction for 2027 - tradingview.com

SENORES Forecast — Price Target — Prediction for 2027  tradingview.com

SENORES Forecast — Price Target — Prediction for 2027 - tradingview.com

Click here to get full coverage on Senores Pharmaceuticals' (NSE:SENORES) Solid Profits Have Weak Fundamentals - simplywall.st

Senores Pharmaceuticals' (NSE:SENORES) Solid Profits Have Weak Fundamentals  simplywall.st

Senores Pharmaceuticals' (NSE:SENORES) Solid Profits Have Weak Fundamentals - simplywall.st

Click here to get full coverage on Senores Pharma earns 2026 Great Place To Work certification - Indian Pharma Post

Senores Pharma earns 2026 Great Place To Work certification  Indian Pharma Post

Senores Pharma earns 2026 Great Place To Work certification - Indian Pharma Post

Click here to get full coverage on Senores Pharmaceuticals to acquire Apnar Pharma, five ANDAs for Rs91 Cr - pharma.economictimes.indiatimes.com

Senores Pharmaceuticals to acquire Apnar Pharma, five ANDAs for Rs91 Cr  pharma.economictimes.indiatimes.com

Senores Pharmaceuticals to acquire Apnar Pharma, five ANDAs for Rs91 Cr - pharma.economictimes.indiatimes.com

Click here to get full coverage on Senores Pharmaceuticals Acquires Apnar Pharma, Five ANDAs In Rs 91-Crore Deal - bwhealthcareworld.com

Senores Pharmaceuticals Acquires Apnar Pharma, Five ANDAs In Rs 91-Crore Deal  bwhealthcareworld.com

Senores Pharmaceuticals Acquires Apnar Pharma, Five ANDAs In Rs 91-Crore Deal - bwhealthcareworld.com

Click here to get full coverage on Should You Be Adding Senores Pharmaceuticals (NSE:SENORES) To Your Watchlist Today? - simplywall.st

Should You Be Adding Senores Pharmaceuticals (NSE:SENORES) To Your Watchlist Today?  simplywall.st

Should You Be Adding Senores Pharmaceuticals (NSE:SENORES) To Your Watchlist Today? - simplywall.st

Click here to get full coverage on Senores makes bold US push with new federal-focused JV - Indian Pharma Post

Senores makes bold US push with new federal-focused JV  Indian Pharma Post

Senores makes bold US push with new federal-focused JV - Indian Pharma Post

Click here to get full coverage on Senores Pharma posts ₹180 crore in Q1 FY27 - pharma.economictimes.indiatimes.com

Senores Pharma posts ₹180 crore in Q1 FY27  pharma.economictimes.indiatimes.com

Senores Pharma posts ₹180 crore in Q1 FY27 - pharma.economictimes.indiatimes.com

Click here to get full coverage on Senores Pharmaceuticals Ltd Key Financial Ratios – Valuation, Profitability & More - Value Research

Senores Pharmaceuticals Ltd Key Financial Ratios – Valuation, Profitability & More  Value Research

Senores Pharmaceuticals Ltd Key Financial Ratios – Valuation, Profitability & More - Value Research

Click here to get full coverage on Senores Pharmaceuticals files FY26 sustainability report with exchanges - scanx.trade

Senores Pharmaceuticals files FY26 sustainability report with exchanges  scanx.trade

Senores Pharmaceuticals files FY26 sustainability report with exchanges - scanx.trade

Click here to get full coverage on Senores Pharmaceuticals schedules 9th AGM for September 25, 2026 - scanx.trade

Senores Pharmaceuticals schedules 9th AGM for September 25, 2026  scanx.trade

Senores Pharmaceuticals schedules 9th AGM for September 25, 2026 - scanx.trade

Click here to get full coverage on Senores enters into US government procurement market - Business Standard

Senores enters into US government procurement market  Business Standard

Senores enters into US government procurement market - Business Standard

Click here to get full coverage on Senores Pharmaceuticals: Commercialisation Momentum Strengthens Outlook - Moneylife

Senores Pharmaceuticals: Commercialisation Momentum Strengthens Outlook  Moneylife

Senores Pharmaceuticals: Commercialisation Momentum Strengthens Outlook - Moneylife

Click here to get full coverage on Buy Senores Pharma; target of Rs 1795: Choice Institutional Equities - Moneycontrol.com

Buy Senores Pharma; target of Rs 1795: Choice Institutional Equities  Moneycontrol.com

Buy Senores Pharma; target of Rs 1795: Choice Institutional Equities - Moneycontrol.com

Click here to get full coverage on Senores Pharma Q1 Results: Regulated markets power 56% profit growth, margin expansion - CNBC TV18

Senores Pharma Q1 Results: Regulated markets power 56% profit growth, margin expansion  CNBC TV18

Senores Pharma Q1 Results: Regulated markets power 56% profit growth, margin expansion - CNBC TV18

Click here to get full coverage on SENORES Share Price Rises 5.04% | Market Cap Rs 6,572 Cr - univest.in

SENORES Share Price Rises 5.04% | Market Cap Rs 6,572 Cr  univest.in

SENORES Share Price Rises 5.04% | Market Cap Rs 6,572 Cr - univest.in

Click here to get full coverage on Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities - Moneycontrol.com

Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities  Moneycontrol.com

Buy Senores Pharma; target of Rs 1640: Choice Institutional Equities - Moneycontrol.com

Click here to get full coverage on Senores Pharmaceuticals to hold investor conference on June 12 - scanx.trade

Senores Pharmaceuticals to hold investor conference on June 12  scanx.trade

Senores Pharmaceuticals to hold investor conference on June 12 - scanx.trade

Click here to get full coverage on Senores Pharma Reports 77.5% Rise in Q4 Net Profit to ₹316 Million YoY - Sahi

Senores Pharma Reports 77.5% Rise in Q4 Net Profit to ₹316 Million YoY  Sahi

Senores Pharma Reports 77.5% Rise in Q4 Net Profit to ₹316 Million YoY - Sahi

Click here to get full coverage on Senores Pharma approves Mexico, Canada subsidiaries and ESOS - scanx.trade

Senores Pharma approves Mexico, Canada subsidiaries and ESOS  scanx.trade

Senores Pharma approves Mexico, Canada subsidiaries and ESOS - scanx.trade

Click here to get full coverage on Senores Pharmaceuticals Forms Strategic US Joint Venture for Federal Contracts - scanx.trade

Senores Pharmaceuticals Forms Strategic US Joint Venture for Federal Contracts  scanx.trade

Senores Pharmaceuticals Forms Strategic US Joint Venture for Federal Contracts - scanx.trade

Click here to get full coverage on Senores Pharmaceuticals issues ₹62 crore corporate guarantee for subsidiary - scanx.trade

Senores Pharmaceuticals issues ₹62 crore corporate guarantee for subsidiary  scanx.trade

Senores Pharmaceuticals issues ₹62 crore corporate guarantee for subsidiary - scanx.trade

Click here to get full coverage on Senores Pharma Q3 FY26 Profit Doubles as Regulated Markets Drive 64% Revenue Growth - Medical Dialogues

Senores Pharma Q3 FY26 Profit Doubles as Regulated Markets Drive 64% Revenue Growth  Medical Dialogues

Senores Pharma Q3 FY26 Profit Doubles as Regulated Markets Drive 64% Revenue Growth - Medical Dialogues

Click here to get full coverage on Senores Pharma profit surges 56% in Q1FY27; eyes ₹3,000 cr revenue - scanx.trade

Senores Pharma profit surges 56% in Q1FY27; eyes ₹3,000 cr revenue  scanx.trade

Senores Pharma profit surges 56% in Q1FY27; eyes ₹3,000 cr revenue - scanx.trade

Click here to get full coverage on Senores Pharma to buy Apnar Pharma at enterprise value of Rs 91 crore - Medical Dialogues

Senores Pharma to buy Apnar Pharma at enterprise value of Rs 91 crore  Medical Dialogues

Senores Pharma to buy Apnar Pharma at enterprise value of Rs 91 crore - Medical Dialogues

Click here to get full coverage on Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs - Express Pharma

Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs  Express Pharma

Senores Pharmaceuticals to acquire Apnar Pharma and five ANDAs - Express Pharma

Click here to get full coverage on Senores Pharmaceuticals Shareholders Approve All 8 Resolutions in Postal Ballot Concluded August 4, 2026 - scanx.trade

Senores Pharmaceuticals Shareholders Approve All 8 Resolutions in Postal Ballot Concluded August 4, 2026  scanx.trade

Senores Pharmaceuticals Shareholders Approve All 8 Resolutions in Postal Ballot Concluded August 4, 2026 - scanx.trade

Click here to get full coverage on Senores Pharmaceuticals to host investor conference in Mumbai on Sep 2 - scanx.trade

Senores Pharmaceuticals to host investor conference in Mumbai on Sep 2  scanx.trade

Senores Pharmaceuticals to host investor conference in Mumbai on Sep 2 - scanx.trade

Click here to get full coverage on Senores Pharma arm facility gets USFDA EIR - Medical Dialogues

Senores Pharma arm facility gets USFDA EIR  Medical Dialogues

Senores Pharma arm facility gets USFDA EIR - Medical Dialogues

Click here to get full coverage on Senores Pharmaceuticals eyes 30–40% revenue growth in FY27 amid product launches - CNBC TV18

Senores Pharmaceuticals eyes 30–40% revenue growth in FY27 amid product launches  CNBC TV18

Senores Pharmaceuticals eyes 30–40% revenue growth in FY27 amid product launches - CNBC TV18

Click here to get full coverage on Senores Pharma Consolidated March 2026 Net Sales at Rs 175.19 crore, up 53.39% Y-o-Y - Moneycontrol.com

Senores Pharma Consolidated March 2026 Net Sales at Rs 175.19 crore, up 53.39% Y-o-Y  Moneycontrol.com

Senores Pharma Consolidated March 2026 Net Sales at Rs 175.19 crore, up 53.39% Y-o-Y - Moneycontrol.com

Click here to get full coverage on Senores Pharmaceuticals receives Philippine FDA approval for 10 products - Express Pharma

Senores Pharmaceuticals receives Philippine FDA approval for 10 products  Express Pharma

Senores Pharmaceuticals receives Philippine FDA approval for 10 products - Express Pharma

Click here to get full coverage on Stocks to buy: Apollo Hospitals, Senores Pharma among analyst's top picks - Business Standard

Stocks to buy: Apollo Hospitals, Senores Pharma among analyst's top picks  Business Standard

Stocks to buy: Apollo Hospitals, Senores Pharma among analyst's top picks - Business Standard

Click here to get full coverage on Senores Pharmaceuticals hosts investor meet in Mumbai on August 25 - scanx.trade

Senores Pharmaceuticals hosts investor meet in Mumbai on August 25  scanx.trade

Senores Pharmaceuticals hosts investor meet in Mumbai on August 25 - scanx.trade

Click here to get full coverage on SENORES PHARMACEUTICALS L Share Price: Fresh 52-Week High - univest.in

SENORES PHARMACEUTICALS L Share Price: Fresh 52-Week High  univest.in

SENORES PHARMACEUTICALS L Share Price: Fresh 52-Week High - univest.in

Click here to get full coverage on Senores Pharma Q4 Results: Stock drops 5% on sequential earnings weakness - CNBC TV18

Senores Pharma Q4 Results: Stock drops 5% on sequential earnings weakness  CNBC TV18

Senores Pharma Q4 Results: Stock drops 5% on sequential earnings weakness - CNBC TV18

Click here to get full coverage on Senores Pharma posts 105% PAT in Q3, on a ‘secular’ revenue mix - BusinessLine

Senores Pharma posts 105% PAT in Q3, on a ‘secular’ revenue mix  BusinessLine

Senores Pharma posts 105% PAT in Q3, on a ‘secular’ revenue mix - BusinessLine

Click here to get full coverage on Senores Pharmaceuticals schedules analyst meeting on July 7 - scanx.trade

Senores Pharmaceuticals schedules analyst meeting on July 7  scanx.trade

Senores Pharmaceuticals schedules analyst meeting on July 7 - scanx.trade

Click here to get full coverage on Senores Pharma expects to beat FY26 growth target: MD Swapnil Shah - CNBC TV18

Senores Pharma expects to beat FY26 growth target: MD Swapnil Shah  CNBC TV18

Senores Pharma expects to beat FY26 growth target: MD Swapnil Shah - CNBC TV18

Click here to get full coverage on Senores Pharmaceuticals announces senior management changes with CTO appointment and R&D head resignation - scanx.trade

Senores Pharmaceuticals announces senior management changes with CTO appointment and R&D head resignation  scanx.trade

Senores Pharmaceuticals announces senior management changes with CTO appointment and R&D head resignation - scanx.trade

Click here to get full coverage on SENORES PHARMACEUTICALS L Share Price Near 52-Week High - univest.in

SENORES PHARMACEUTICALS L Share Price Near 52-Week High  univest.in

SENORES PHARMACEUTICALS L Share Price Near 52-Week High - univest.in

Click here to get full coverage on Senores Pharma forms new subsidiary to strengthen its US footprint - Express Pharma

Senores Pharma forms new subsidiary to strengthen its US footprint  Express Pharma

Senores Pharma forms new subsidiary to strengthen its US footprint - Express Pharma

Click here to get full coverage on Senores Pharmaceuticals Q1 Results: Earnings Call Audio Released for Quarter Ended June 30, 2026 - scanx.trade

Senores Pharmaceuticals Q1 Results: Earnings Call Audio Released for Quarter Ended June 30, 2026  scanx.trade

Senores Pharmaceuticals Q1 Results: Earnings Call Audio Released for Quarter Ended June 30, 2026 - scanx.trade

Click here to get full coverage on Senores Pharmaceuticals Q1 FY27 Results Preview - univest.in

Senores Pharmaceuticals Q1 FY27 Results Preview  univest.in

Senores Pharmaceuticals Q1 FY27 Results Preview - univest.in

Click here to get full coverage on Senores Pharma expands US footprint with Zoraya acquisition, EIR nod - Healthcare Radius

Senores Pharma expands US footprint with Zoraya acquisition, EIR nod  Healthcare Radius

Senores Pharma expands US footprint with Zoraya acquisition, EIR nod - Healthcare Radius

Click here to get full coverage on Buy Senores Pharma; target of Rs 1045: Choice Institutional Equities - Moneycontrol.com

Buy Senores Pharma; target of Rs 1045: Choice Institutional Equities  Moneycontrol.com

Buy Senores Pharma; target of Rs 1045: Choice Institutional Equities - Moneycontrol.com

Click here to get full coverage on Senores Pharmaceuticals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook - univest.in

Senores Pharmaceuticals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook  univest.in

Senores Pharmaceuticals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook - univest.in

Click here to get full coverage on Senores Pharmaceuticals Schedules Board Meeting on May 14, 2026 to Approve FY26 Audited Financial Results - scanx.trade

Senores Pharmaceuticals Schedules Board Meeting on May 14, 2026 to Approve FY26 Audited Financial Results  scanx.trade

Senores Pharmaceuticals Schedules Board Meeting on May 14, 2026 to Approve FY26 Audited Financial Results - scanx.trade

Click here to get full coverage on Senores Pharmaceuticals to acquire Apnar Pharma for enterprise value of ₹91 crore - CNBC TV18

Senores Pharmaceuticals to acquire Apnar Pharma for enterprise value of ₹91 crore  CNBC TV18

Senores Pharmaceuticals to acquire Apnar Pharma for enterprise value of ₹91 crore - CNBC TV18

Click here to get full coverage on Multibaggers: 12 stocks with profit margins above 10% for 4 straight quarters. Do you own any? - The Economic Times

Multibaggers: 12 stocks with profit margins above 10% for 4 straight quarters. Do you own any?  The Economic Times

Multibaggers: 12 stocks with profit margins above 10% for 4 straight quarters. Do you own any? - The Economic Times

Click here to get full coverage on Senores Pharmaceuticals Share Price Target 2026: Rs 1,500 Analyst Forecast - univest.in

Senores Pharmaceuticals Share Price Target 2026: Rs 1,500 Analyst Forecast  univest.in

Senores Pharmaceuticals Share Price Target 2026: Rs 1,500 Analyst Forecast - univest.in

Click here to get full coverage on Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore - India Infoline

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore  India Infoline

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore - India Infoline

Click here to get full coverage on Senores Pharma slumps as Q3 PAT slides 2% QoQ to Rs 32 cr - Business Standard

Senores Pharma slumps as Q3 PAT slides 2% QoQ to Rs 32 cr  Business Standard

Senores Pharma slumps as Q3 PAT slides 2% QoQ to Rs 32 cr - Business Standard

Click here to get full coverage on Senores Pharmaceuticals Limited Welcomes Mr. Jatin Gajjar as Chief Technology Officer - hrtoday.in

Senores Pharmaceuticals Limited Welcomes Mr. Jatin Gajjar as Chief Technology Officer  hrtoday.in

Senores Pharmaceuticals Limited Welcomes Mr. Jatin Gajjar as Chief Technology Officer - hrtoday.in

Click here to get full coverage on Senores Pharmaceuticals Issues USD 1.5 Million Corporate Guarantee for US Subsidiary - scanx.trade

Senores Pharmaceuticals Issues USD 1.5 Million Corporate Guarantee for US Subsidiary  scanx.trade

SENORES

Price Chart

Key Statistics

Technicals

About SENORES

Latest News

Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility - tradingview.com

Briefs: Senores Pharmaceuticals and KIMS - Indian Pharma Post

Senores Pharma targets ₹3,000 crore revenue in 3-5 years, expands India and US capacity - CNBC TV18

Advanced Charts

Top Gainers

Top Losers